GET DAILY SIGNALSWhy Is Twist Bioscience (TWST) Stock Down -9.15% Today?
Key Takeaways
- TWST shares fell 9.15% to $129.53, down from a prior close of $142.58, as a broad risk-off wave hit AI and genomics names.
- The decline came with no company-specific news, driven instead by profit-taking and stretched valuations after a massive multi-month rally.
- Investor anxiety over AI-related capital spending, reignited by big-tech earnings, pressured the sector in sympathy.
- The stock had more than quadrupled over the past year on AI-driven drug discovery enthusiasm, leaving it vulnerable to a pullback.
- Traders are now focused on Twist Bioscience's fiscal fourth-quarter results, scheduled for Thursday, November 12, 2026.
- For deeper analysis, explore Price Targets, Earnings, and Forecast data on Tickeron.
- Discover which strategies are performing best in today's market by exploring Trending AI Robots.
Opening Summary
Twist Bioscience Corporation (TWST), a synthetic biology and genomics company whose silicon-based DNA synthesis platform powers applications across diagnostics, therapeutics, agriculture, and AI-driven drug discovery, tumbled 9.15% on Wednesday. The shares closed at $129.53, down $13.05 from the prior session's close of $142.58. The move lower came without a single company-specific catalyst, as a broad selloff in artificial intelligence and genomics stocks dragged the high-flying name into a sharp pullback.
Broad AI and Genomics Risk-Off Sentiment
The primary driver of Wednesday's decline was a broader market rotation out of richly valued technology and AI-adjacent stocks. Concerns over the pace and returns on AI capital spending, reignited by earnings from major technology platforms, spilled over into the genomics tools sector, where TWST has increasingly traded as a proxy for AI-enabled biology. Peers and sector ETFs moved lower in tandem, signaling that the pullback was sentiment-driven rather than the result of a change in Twist Bioscience's fundamental outlook.
Profit-Taking After a Massive Run
The scale of Wednesday's decline also reflects the extraordinary run that preceded it. TWST had more than quadrupled over the past year, fueled by enthusiasm for AI-driven drug discovery, including its antibody data agreement with Eli Lilly's TuneLab platform and analyst calls naming the company a key beneficiary of AI's push into biology research. After such a surge, the stock carried a forward sales multiple roughly double its five-year average, leaving it especially susceptible to a valuation reset when risk appetite cooled. Wednesday's selloff functioned as a sharp repricing of that premium.
Market Context and Trading Activity
The decline unfolded as the broader market turned defensive, with technology-heavy indices and genomics peers selling off in sympathy. Trading volume in TWST was elevated relative to its recent daily average, consistent with institutions and retail investors reducing exposure to momentum names. The move pushed the stock well off its recent highs, underscoring how quickly sentiment can reverse in a stock that had become tightly correlated with AI-related trading flows rather than its own earnings cadence.
What Comes Next for TWST
Attention now turns to Twist Bioscience's fiscal 2026 fourth-quarter and full-year results, due before the market opens on Thursday, November 12, 2026. The company has guided to record fourth-quarter revenue of roughly $123 million to $124 million and reiterated its target of reaching adjusted EBITDA breakeven for the quarter. In its most recent quarter, revenue rose 23% year over year to $118.4 million, driven by strong growth in DNA synthesis and therapeutics, though a wider-than-expected net loss weighed on sentiment. Investors will be watching for confirmation of continued growth, progress toward profitability, and any update on AI-enabled order momentum, alongside broader market and interest-rate dynamics that could influence risk appetite for high-multiple growth names.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of bots covering thousands of tickers, each with its own strategy, timeframe, performance metrics, and traded symbols. By focusing on the strongest performers, the page helps traders identify strategies that are adapting well to today's shifting market environment. Explore the page to see which approaches are currently leading.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TWST's Stochastic Oscillator remains in oversold zone for 1 day
Be on the lookout for a price bounce soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +10.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where TWST advanced for three days, in 235 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for TWST moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In 38 of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TWST as a result. In 66 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for TWST turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 39 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
TWST moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TWST crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TWST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
TWST broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TWST entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.208) is normal, around the industry mean (2.904). P/E Ratio (-63.937) is within average values for comparable stocks, (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (20.243) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. TWST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TWST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of proprietary semiconductor-based synthetic DNA manufacturing process
Industry Biotechnology
Advertisement